Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial

REPLACE investigators

研究成果: Article同行評審

4 引文 斯高帕斯(Scopus)

指紋

深入研究「Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial」主題。共同形成了獨特的指紋。

Medicine & Life Sciences